Concept Life Sciences offers a comprehensive service for pre-formulation and formulation development plus GMP sample production for pre-clinical trial materials. We test and release formulations according to development specifications and produce samples under GMP conditions ready for transfer to study teams.
Our formulation team undertake programmes such as maximising the in-vivo exposure of a NCE for toxicity assessing, formulation de-risking programmes, solubility enhancement via excipient screening (using our proprietary solubility screen), developing amorphous solid dispersions, particle size reduction via milling to generate suspensions of nano-sized API in a suitable dosing vehicle (nanosuspension).
We have available a wide range of characterisation tools in support of formulation development encompassing parenteral, oral, topical and inhalation products.
Additional solid form optimisation services such as polymorph screening / salt screening, micronising or blending to prepare samples for further development can be undertaken in house; these services are also supported by a full suite of physical and chemical characterisation techniques.
Additional API processing services such as micronising or blending to prepare samples for further development can be undertaken and we carry out such work on site with characterisation analysis.
• Particle size reduction including micronisation and nano-milling (g to kg)
• Lyophilisation (g to kg)
• Evaporation (e.g. Rotary Evaporation to 10L)
• Generation of amorphous material (e.g. HME and spray drying)